MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.600
+0.010
+0.63%
After Hours: 1.620 +0.02 +1.23% 19:56 02/20 EST
OPEN
1.600
PREV CLOSE
1.590
HIGH
1.659
LOW
1.560
VOLUME
6.16M
TURNOVER
--
52 WEEK HIGH
1.960
52 WEEK LOW
0.5150
MARKET CAP
523.71M
P/E (TTM)
-7.3801
1D
5D
1M
3M
1Y
5Y
1D
Ocugen Inc. Stock Rises 7.4%, Outperforms Market
Dow Jones · 2d ago
Ocugen Inc. Updates Financial Calendar
Reuters · 3d ago
Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Barchart · 3d ago
Weekly Report: what happened at OCGN last week (0209-0213)?
Weekly Report · 5d ago
Top small-cap healthcare stocks surging above 200-day moving average
Seeking Alpha · 02/11 19:37
Ocugen setzt neue Vergütungsregelungen für CFO Rita Johnson-Greene fest
Reuters · 02/09 13:00
Ocugen Announces New CFO Compensation Package with Severance and Equity Acceleration Terms
Reuters · 02/09 13:00
Ocugen taps Rita Johnson-Greene as CFO
Seeking Alpha · 02/09 12:07
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.